1186649-91-1 (ML-109,ML-109)

化合物ML-109;

ML-109;Acetamide, N-[4-[[2-methoxy-5-[1,2,3,4-tetrahydro-5-hydroxy-4-oxo-3-(phenylmethyl)-2-quinazolinyl]phenyl]methoxy]phenyl]-;N-[4-[[2-Methoxy-5-[1,2,3,4-tetrahydro-5-hydroxy-4-oxo-3-(phenylmethyl)-2-quinazolinyl]phenyl]methoxy]phenyl]acetamide;ML-109 (CID-25246343);TSH Receptor,Thyrotropin receptor,inhibit,ML-109,ML 109,Inhibitor,Thyroid-stimulating hormone Receptor,ML109;DA-55542;NCGC00161870-01;CHEBI:91942;ML 109; ML109;GLXC-02618;1186649-91-1;D81075;CHEMBL1515891;(+/-)-NCGC00161870;N-(4-{[5-(3-benzyl-5-hydroxy-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-2-methoxyphenyl]methoxy}phenyl)acetamide;DTXSID401015743;BDBM50496706;AKOS037648530;ML109;N-[4-[[5-[5-hydroxy-4-oxo-3-(phenylmethyl)-1,2-dihydroquinazolin-2-yl]-2-methoxyphenyl]methoxy]phenyl]acetamide;BCP33850;CS-0069880;SCHEMBL2240866;AC-36479;N-[4-[[5-(3-benzyl-5-hydroxy-4-oxo-1,2-dihydroquinazolin-2-yl)-2-methoxyphenyl]methoxy]phenyl]acetamide;BS-14451;MFCD31746908;ML-109?;N-(4-((5-(3-Benzyl-5-hydroxy-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-2-methoxybenzyl)oxy)phenyl)acetamide;HY-114116;MLS002576689;EX-A3616;N-(4-(5-(3-benzyl-5-hydroxy-4-oxo-1,2,3,4-tetrahydroquinazolin-2-yl)-2-methoxybenzyloxy)phenyl)-acetamide;SMR001496544;N-(4-{[5-(3-benzyl-5-hydroxy-4-oxo-1,2-dihydroquinazolin-2-yl)-2-methoxyphenyl]methoxy}phenyl)acetamide;Q27163740;

JRVXFGNCHKHBPA-UHFFFAOYSA-N

1S/C31H29N3O5/c1-20(35)32-24-12-14-25(15-13-24)39-19-23-17-22(11-16-28(23)38-2)30-33-26-9-6-10-27(36)29(26)31(37)34(30)18-21-7-4-3-5-8-21/h3-17,30,33,36H,18-19H2,1-2H3,(H,32,35)

C(NC1=CC=C(OCC2=CC(C3N(CC4=CC=CC=C4)C(=O)C4=C(N3)C=CC=C4O)=CC=C2OC)C=C1)(=O)C